fgk-cro.hu

What It Is

FGK Clinical Research Kft. is a full-service contract research organization (CRO) based in Budapest, Hungary, serving pharmaceutical, biotechnology, and medical device companies. Based on its website, its focus is not standard SaaS subscription software, but professional services around clinical development, including consulting, regulatory affairs, project management, data management, biostatistics, medical safety, pharmacovigilance, and legal representation.

Core Capabilities and Compliance

FGK’s services cover the clinical trial lifecycle: early protocol design, sample size calculation, adaptive design, country and site selection, regulatory communication, ethics committee submissions, project management/monitoring, medical writing, and quality assurance. Its strengths are concentrated in the European regulatory environment. It explicitly states familiarity with EU and national regulations for medicines, medical devices, and different study types, and follows standards such as ICH-GCP, ISO 14155, and ISO 20916.

On the data side, its CDISC compliance capabilities are described in fairly solid detail: it can support SDTM and ADaM programming and documentation, generate define.xml and SDTM/ADaM reviewer’s guides, and use Pinnacle 21 for validation. Its services can be used both to standardize data from new trials and to convert legacy clinical trial data into CDISC-compliant datasets.

Pricing and Delivery Model

The website does not disclose fixed packages, subscription fees, or a price list, so this appears to be a project-based/custom-quote model. The representative services page only states that pricing is reasonable. FGK emphasizes a flexible service model: clients can outsource the entire process or use FGK for selected functional support depending on their internal capabilities.

Pros and Cons

The main advantages are its complete service chain, coverage of EU and Swiss legal representation, and case experience and client testimonials in complex areas such as ATMP, cell therapy, medical devices, oncology, and rare diseases. The drawback is that it lacks the information typically seen with SaaS products: there are no clear screenshots of software modules, free trials, account permissions, APIs, third-party integrations, or SLA details. Although eSolutions appears in the navigation, it is not elaborated on in the main content.

Best Fit and Access from China

FGK is better suited to pharmaceutical and medical device companies planning to conduct clinical research in Europe/Switzerland, submit regulatory materials, or prepare CDISC data packages, especially small and midsize companies without a European entity or in-house clinical operations capabilities. Access from China, payment methods, and Chinese-language support are not disclosed, so these should be considered unknown. If localized service is required, companies may also evaluate domestic CROs such as Tigermed, or compare FGK with global CROs such as IQVIA, ICON, Parexel, and Medpace.